Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
43 results
D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab
D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic
D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates
D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results
D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center
D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
D2.382 - Clinical Manifestations of Dust Mite Allergy in Children Under 18 Years of Age
D2.384 - Biostatistics in allergy and clinical immunology: reasons for concern and editorial recommendations
D2.385 - Association between long-term PM2.5 exposure and risk of Urticaria and Allergic rhinitis in children: A nationwide longitudinal cohort study
D2.386 - Quantification of airborne allergens – Comparison between inhalable dust sampling and a new ambient air sampler
D2.387 - Reducing the Carbon Footprint of Cetirizine Prescription: Exploring Patient Perspectives on Formulation Choice in an Allergy Clinic
D2.388 - Greening office spaces: the impact of indoor plants on autonomic nervous system activity
D2.389 - A Dynamic Interaction Between the Immune System, the Exposome, and Climate Change: The Shifting Sensitization Profile to Respiratory Allergens Across Life
D2.390 - Effects of Cigarette Smoke on Expression and Rhythmicity ofr Core Circadian Genes in Peripheral Blood Mononuclear Cells (PBMC) and Bronchial Epithelial Cells
D2.391 - Changing Patterns of Aeroallergen Sensitization in Zagreb: Ragweed as the Predominant Allergen in a Sensitized Adult Population
D2.393 - Balancing Green Initiatives with Public Health: A Framework for Allergy-Friendly Urban Planning
Pagination
Current page
1
Page
2
Page
3
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download